Dr. Tara Tabatabaie, a lawyer and a scientist, concentrates her practice on mass tort litigation, with a primary focus on complex pharmaceutical cases. She also handles a variety of legal issues involving product liability, environmental damage, and toxicity. She represents clients in state, federal, and appellate courts, and mediations. Dr. Tabatabaie currently serves as a member of the Plaintiffs’ Steering Committee in the multidistrict litigation, In re: Actos (Pioglitazone) Products Liability Litigation, MDL 2299, as well as the Science Committees for In re: Propecia (Finasteride) Products Liability Litigation, MDL 2331 and In Re: Fresenius Granuflo/Naturalyte Dialysate Products Liability Litigation. MDL 2428. She also served as a member of the Science Committee in the In re: Avandia Marketing, Sales Practices, and Products Liability Litigation, MDL 1871, where her scientific expertise made significant contributions to the successful resolution of the case that has resulted in a multi-billion dollar settlement for the plaintiffs.
Prior to starting her legal career, Dr. Tabatabaie was a senior research scientist at the Oklahoma Medical Research Foundation in Oklahoma City. In that position, she studied the biomedical processes involved in a variety of diseases, including cancer, diabetes, stroke, heart disease, Alzheimer’s disease, AIDS dementia, and various environmental toxicities. Dr. Tabatabaie is the author of numerous scientific articles and book chapters and has served as the peer reviewer for several prestigious scientific journals. Due to her extensive biomedical research experience, Dr. Tabatabaie is frequently requested to lecture and educate the legal community on the scientific issues involved in pharmaceutical litigation.
Tara is married and lives in Oklahoma City with her husband and their two sons.